Results 121 to 130 of about 51,297 (183)
Research progress of ginseng active ingredients combined with chemotherapy in cancer therapy. [PDF]
Zhang Y +5 more
europepmc +1 more source
Chiral benzo[2.2.1] α-hydroxyketones from a dirhodium(ii)/bisphosphine-catalyzed desymmetrization addition reaction. [PDF]
Zhan S, Wang C, Duan L, Gu Z.
europepmc +1 more source
Enantioselective intramolecular cyclopropanation via a cationic sulfoxonium-Rh-carbene. [PDF]
Xing Y +6 more
europepmc +1 more source
Rhodium-catalysed connective synthesis of diverse reactive probes bearing S(VI) electrophilic warheads. [PDF]
Rice S +6 more
europepmc +1 more source
Targeting Autophagy in Ovarian Cancer: The Emerging Role of Ginsenosides. [PDF]
Guo Y, Yun C, Zhang Y, Yang X, Liu H.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Anticancer Effects of Ginsenoside Rh2: A Systematic Review
Current Molecular Pharmacology, 2021Background: As one of the effective pharmacological constituents of Ginseng Radix et Rhizoma, ginsenoside Rh2 (Rh2) exerts a remarkable anticancer effect on various cancer cell lines in vitro and strongly inhibits tumor growth in vivo without severe toxicity. Objective: This article reviewed existing evidence supporting the anticancer effects of Rh2
Xin-Ling, He +6 more
openaire +2 more sources
Asymmetric, redox-active carbonyl complexes with [Rh2]2+, [Rh2]3+, and [Rh2]4+ cores
Journal of the Chemical Society, Chemical Communications, 1987The [Rh2]2+ complex [Rh2(CO)2(bipy)(µ-RNNNR)2](2, bipy = 2,2′-bipyridyl, R =p-tolyl) is the precursor to asymmetric, redox-active [Rh2]3+ and [Rh2]4+ derivatives such as [Rh2(CO)L(bipy)(µ-RNNNR)2]z(3+, L = PPh3, z= 1; 4, L = I, z= 0) and [Rh2(CO)(S2CNMe2)(piby)(µ-RNNNR)2][PF6](5) respectively.
Neil G. Connelly, Gabriel Garcia
openaire +1 more source

